PTC Therapeutics (PTCT)
NASDAQ:PTCT
US Market
Advertisement

PTC Therapeutics (PTCT) Technical Analysis

Compare
401 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
PTC Therapeutics’s (PTCT) Moving Averages Convergence Divergence (MACD) indicator is 2.94, suggesting PTC Therapeutics is a Sell.
PTC Therapeutics’s (PTCT) 20-Day exponential moving average is 70.95, while PTC Therapeutics’s (PTCT) share price is $75.6, making it a Buy.
PTC Therapeutics’s (PTCT) 50-Day exponential moving average is 65.82, while PTC Therapeutics’s (PTCT) share price is $75.6, making it a Buy.

PTC Therapeutics (PTCT) Pivot Points

Nov 18, 2025, 10:29 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
71.22
72.63
73.97
75.38
76.72
78.13
79.47
Fibonacci
72.63
73.68
74.33
75.38
76.43
77.08
78.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

PTC Therapeutics (PTCT) Moving Averages

Nov 18, 2025, 10:29 AM
Period
Simple
Exponential
MA5
74.92Buy
74.69Buy
MA10
73.10Buy
73.24Buy
MA20
70.21Buy
70.95Buy
MA50
65.66Buy
65.82Buy
MA100
57.54Buy
60.50Buy
MA200
53.47Buy
55.48Buy
PTC Therapeutics’s (PTCT) 10-Day exponential moving average is 73.24, while PTC Therapeutics’s (PTCT) share price is $75.6, making it a Buy.
PTC Therapeutics’s (PTCT) 100-Day exponential moving average is 60.50, while PTC Therapeutics’s (PTCT) share price is $75.6, making it a Buy.
PTC Therapeutics’s (PTCT) stock price is $75.6 and PTC Therapeutics’s (PTCT) 50-day simple moving average is 65.66, creating a Buy signal.
PTC Therapeutics’s (PTCT) stock price is $75.6 and PTC Therapeutics’s (PTCT) 100-day simple moving average is 57.54, creating a Buy signal.
PTC Therapeutics’s (PTCT) stock price is $75.6 and PTC Therapeutics’s (PTCT) 200-day simple moving average is 53.47, creating a Buy signal.

PTC Therapeutics (PTCT) Technical Indicators

Nov 18, 2025, 10:29 AM
Name
Value
Implied Action
RSI (14)
77.41
Sell
STOCH (9,6)
86.04
Sell
STOCHRSI (14)
87.03
Sell
MACD (12,26)
2.94
Sell
ADX (14)
38.18
Neutral
Williams %R
-16.15
Sell
CCI (14)
130.93
Sell
ATR (14)
2.53
-
Ultimate Oscillator
63.50
Neutral
ROC
12.02
Buy
PTC Therapeutics’s (PTCT) Relative Strength Index (RSI) is 77.41, creating a Sell signal.
PTC Therapeutics’s (PTCT) Trend Strength Indicator (ADX) is 38.18, creating a Neutral signal.
PTC Therapeutics’s (PTCT) Commodity Channel Index (CCI) is 130.93, creating a Sell signal.
PTC Therapeutics’s (PTCT) Price Rate of Change (ROC) is 12.02, creating a Buy signal.

FAQ

Is PTCT a Buy, Hold, or Sell?
Based on PTCT’s technical indicators, PTCT is a Buy.
    What is PTCT’s RSI (14)?
    PTCT’s RSI (14) is 77.41, which suggests PTCT is a Sell.
      What is PTCT’s MACD?
      PTCT’s MACD is 2.94, which suggests PTCT is a Sell.
        What is PTCT’s 5-day moving average?
        PTCT’s 5-day moving average is 74.92, which suggests PTCT is a Buy.
          What is PTCT’s 20-day moving average?
          PTCT 20-day moving average is 70.21, which suggests PTCT is a Buy.
            What is PTCT’s 50-day moving average?
            PTCT’s 50-day moving average is 65.66, which suggests PTCT is a Buy.
              What is PTCT’s 200-day moving average?
              PTCT’s 200-day moving average is 53.47, which suggests PTCT is a Buy.
                What is PTCT’s Williams % R (14)?
                PTCT’s Williams % R (14) is -16.15, which suggests PTCT is a Sell.
                  What is PTCT’s CCI (14)?
                  PTCT’s CCI (14) is 130.93, which suggests PTCT is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis